CUE

Cue Biopharma Inc

Jun 17 • 03:12PM ET

25.61

+1.73 7.22 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN EDSA GNLX KZIA PYXS VRCA VTVT GALT IMUX SPRO

| Held by: VTI VXF DFAS AVSC DFAU DFMC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.53	Insider Own	9.90%	Shs Outstand	4.20M	Perf Week	-8.06%
Market Cap	107.60M	Forward P/E	-	EPS next Y	-9.45	Insider Trans	352.09%	Shs Float	3.78M	Perf Month	19.81%
Enterprise Value	94.66M	PEG	-	EPS next Q	-1.69	Inst Own	16.98%	Short Float	7.35%	Perf Quarter	222.93%
Income	-19.52M	P/S	3.29	EPS this Y	20.95%	Inst Trans	-1.12%	Short Ratio	0.38	Perf Half Y	84.61%
Sales	32.73M	P/B	3.86	EPS next Y	-42.32%	ROA	-73.49%	Short Interest	0.28M	Perf YTD	179.58%
Book/sh	6.64	P/C	6.57	EPS next 5Y	-	ROE	-138.52%	52W High	41.42 -38.16%	Perf Year	47.19%
Cash/sh	3.90	P/FCF	-	EPS past 3/5Y	42.63% 29.04%	ROIC	-83.13%	52W Low	4.97 415.29%	Perf 3Y	-78.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	180.45% 54.16%	Gross Margin	99.01%	Volatility	15.05% 14.14%	Perf 5Y	-93.49%
Dividend TTM	-	EV/Sales	2.89	EPS Y/Y TTM	72.33%	Oper. Margin	-59.83%	ATR (14)	3.94	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.57	Sales Y/Y TTM	309.60%	Profit Margin	-59.65%	RSI (14)	51.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.57	EPS Q/Q	78.25%	SMA20	2.46%	Beta	2.52	Target Price	115.00
Payout	-	Debt/Eq	0.16	Sales Q/Q	1250.59%	SMA50	11.06%	Rel Volume	0.08	Prev Close	23.89
Employees	29	LT Debt/Eq	0.09	Earnings	May 14 AMC	SMA200	51.28%	Avg Volume	734.45K	Price	25.61
IPO	Jan 02, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	52,797	Change	7.22%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)